|
Multiple sclerosis
Citations 361-370 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
A mutated CCR5 gene may have favorable prognostic implications in MS
- Rami Kantor, Mary Bakhanashvili, and Anat Achiron
Neurology 2003; 61: 238-240.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
 -Fodrin autoantibodies in the differential diagnosis of MS and Sjögren syndrome
- J. de Seze, S. Dubucquoi, A. L. Fauchais, T. Matthias, D. Devos, G. Castelnovo, T. Stojkovic, D. Ferriby, E. Hachulla, P. Labauge, D. Lefranc, P. Y. Hatron, P. Vermersch, and T. Witte
Neurology 2003; 61: 268-269.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Chlamydia pneumoniae in children with MS: Frequency and quantity of intrathecal antibodies
- K. Rostasy, H. Reiber, D. Pohl, P. Lange, A. Ohlenbusch, H. Eiffert, M. Maass, and F. Hanefeld
Neurology 2003; 61: 125-128.
[Abstract]
[Full text]
[PDF]
- ARTICLES
The immune response against herpesvirus is more prominent in the early stages of MS
- P. Villoslada, C. Juste, M. Tintore, V. Llorenç, G. Codina, P. Pozo-Rosich, and X. Montalban
Neurology 2003; 60: 1944-1948.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
- M. Wylezinska, A. Cifelli, P. Jezzard, J. Palace, M. Alecci, and P. M. Matthews
Neurology 2003; 60: 1949-1954.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized controlled study of the acute and chronic effects of cooling therapy for MS
-
Neurology 2003; 60: 1955-1960.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients
- C. Christodoulou, L. B. Krupp, Z. Liang, W. Huang, P. Melville, C. Roque, W. F. Scherl, T. Morgan, W. S. MacAllister, L. Li, L. A. Tudorica, X. Li, P. Roche, and R. Peyster
Neurology 2003; 60: 1793-1798.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Longitudinal MRI study: The effects of azathioprine in MS patients refractory to interferon ß-1b
- S. Markovic–Plese, B. Bielekova, N. Kadom, T. P. Leist, R. Martin, J. A. Frank, and H. F. McFarland
Neurology 2003; 60: 1849-1851.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Contrasting effects of IFNß and IVIG in children with central and peripheral demyelination
- I. Pirko, N. L. Kuntz, M. Patterson, B. M. Keegan, B. G. Weinshenker, and M. Rodriguez
Neurology 2003; 60: 1697-1699.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN ß-1b
- M. P. Sormani, P. Bruzzi, K. Beckmann, K. Wagner, D. H. Miller, L. Kappos, and M. Filippi
Neurology 2003; 60: 1462-1466.
[Abstract]
[Full text]
[PDF]
|
|
